نتایج جستجو برای: akathisia

تعداد نتایج: 522  

Journal: :Schizophrenia research 2005
Guy Chouinard Howard C Margolese

The Extrapyramidal Symptom Rating Scale (ESRS) was developed to assess four types of drug-induced movement disorders (DIMD): Parkinsonism, akathisia, dystonia, and tardive dyskinesia (TD). Comprehensive ESRS definitions and basic instructions are given. Factor analysis provided six ESRS factors: 1) hypokinetic Parkinsonism; 2) orofacial dyskinesia; 3) trunk/limb dyskinesia; 4) akathisia; 5) tre...

2011
Jieun Lee Sung Joon Cho Kang Soo Lee Keunyoung Yook Ah Young Choe Sungjae Lee Borah Kim Keung-Hyang Kim Tae Kyou Choi Sang-Hyuk Lee

OBJECTIVE Some patients with schizophrenia may need mirtazapine augmentation to improve negative and cognitive symptoms. However there have been a few studies about the tolerability of mirtazapine augmentation to antipsychotics such as akathisia, extrapyramydal symptoms, weight gain, and body mass index (BMI). METHODS This study was an eight-week double-blind, randomized controlled trial (RCT...

Journal: :BMC Neurology 2008
Sven Janno Matti M Holi Katinka Tuisku Kristian Wahlbeck

BACKGROUND Neuroleptic-induced movement disorders (NIMDs) have overlapping co-morbidity. Earlier studies have described typical clinical movement patterns for individual NIMDs. This study aimed to identify specific movement patterns for each individual NIMD using actometry. METHODS A naturalistic population of 99 schizophrenia inpatients using conventional antipsychotics and clozapine was eva...

Journal: :JPEN. Journal of parenteral and enteral nutrition 2015
Arthur R H van Zanten Y Gert van der Meer Willem A Venhuizen Daren K Heyland

Recently, regulatory agencies in North America and Europe re-evaluated the safety of metoclopramide. This resulted in recommendations and restrictions in order to minimize the risk of neurological and other adverse reactions associated with the use of metoclopramide. The side effects in non-ICU patients are as follows: 1. Neurological adverse reactions, including extrapyramidal disorders, dyski...

Journal: :Schizophrenia bulletin 2001
E C Lauterbach W G Carter K M Rathke B H Thomas S D Shillcutt R L Vogel N C Moore J W Mimbs W H Nelson

Of 49 state hospital patients referred for movement disorder consultation for tardive dyskinesia (TD), 11 (23.9%) of 46 meeting inclusion criteria had movement disorders other than TD. These other disorders led to a false diagnosis of TD in 6 subjects (12.2%). Between-day dyskinesia variability affected TD ascertainment in only 3.2 percent of subjects. Prevalences of other neurological conditio...

Journal: :Schizophrenia bulletin 2015
Delbert G Robinson Juan A Gallego Majnu John Georgios Petrides Youssef Hassoun Jian-Ping Zhang Leonardo Lopez Raphael J Braga Serge M Sevy Jean Addington Charles H Kellner Mauricio Tohen Melissa Naraine Natasha Bennett Jessica Greenberg Todd Lencz Christoph U Correll John M Kane Anil K Malhotra

Research findings are particularly important for medication choice for first-episode patients as individual prior medication response to guide treatment decisions is unavailable. We describe the first large-scale double-masked randomized comparison with first-episode patients of aripiprazole and risperidone, 2 commonly used first-episode treatment agents. One hundred ninety-eight participants a...

2016
Tarang Sharma Louise Schow Guski Nanna Freund Peter C Gøtzsche

OBJECTIVE To study serious harms associated with selective serotonin and serotonin-norepinephrine reuptake inhibitors.Design Systematic review and meta-analysis. MAIN OUTCOME MEASURES Mortality and suicidality. Secondary outcomes were aggressive behaviour and akathisia. DATA SOURCES Clinical study reports for duloxetine, fluoxetine, paroxetine, sertraline, and venlafaxine obtained from the ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید